)
Albertsons Companies (ACI) investor relations material
Albertsons Companies Q2 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q2 FY2026 net sales and other revenue fell 0.1% to $18.895B; identical sales excluding fuel declined 0.8%, while digital sales rose 11%.
GAAP net income was $51.5M, or $0.11 per diluted share; adjusted net income was $179.0M, or $0.36, and adjusted EBITDA was $784.0M versus $848.4M YoY.
Management acknowledged sales, earnings and market-share performance below expectations and accelerated a comprehensive turnaround review focused on execution, costs, customer value and portfolio choices.
Financial highlights
Gross margin was $5.057B versus $5.107B; operating income was $174.5M versus $295.3M YoY.
SG&A was 25.6% of revenue versus 25.4%; excluding fuel, the rate rose 38 bps, primarily due to sales deleveraging and lower pharmacy sales tied to the IRA.
First-28-week revenue was $43.836B versus $43.797B; adjusted net income was $389.3M and adjusted EBITDA was $1.797B, down from $567.3M and $1.959B, respectively.
Q2 interest expense rose $20M YoY to $125M, reflecting higher borrowings and slightly higher average rates.
Outlook and guidance
Fiscal 2026 outlook was suspended pending the comprehensive review; no incremental financial outlook was issued.
By the Q4 earnings call, management plans to provide a refreshed customer strategy, productivity and cost program, pricing framework, portfolio actions, capital allocation framework, KPIs and multi-year financial outlook.
Investor Day is planned for spring 2027 to detail the turnaround roadmap and refreshed financial framework.
- Board proposals passed, human rights proposal failed, dividend raised, and new regional model launched.ACI
AGM 2026 - Identical sales fell 0.8% as digital and pharmacy growth led amid operational realignment and lower outlook.ACI
Q1 2027 - Proxy covers director elections, governance reforms, and robust ESG and compensation practices.ACI
Proxy filing - Key votes include director elections, auditor ratification, and governance amendments.ACI
Proxy filing - Proxy covers director elections, compensation, governance reforms, and ESG priorities.ACI
Proxy filing - Q4 net loss from opioid settlement; digital sales up 16% and dividend raised 13%.ACI
Q4 2026 - Identical sales and digital growth lifted revenue, but margins narrowed and EBITDA declined.ACI
Q1 2026 - Q4 delivered 2.3% ID sales growth and $855M adjusted EBITDA; 2025 targets 1.5%-2.5% growth.ACI
Q4 2025 - Q3 delivered solid sales and digital growth, but faces post-merger litigation and margin pressure.ACI
Q3 2025
)
)
)
)
)
)
)
)